Disulfiram’s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683

ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome

Ginestier, C., Hur, M. H., Charafe‐Jauffret, E., Monville, F., Dutcher, J. A., Brown, M., Jacquemier, J. D., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,093

Cancer stem cells revisited

Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807

Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily

Marchitti, S. A., Brocker, C. N., Stagos, D., & Vasiliou, V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.697 · Cited by 806

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1630 · Cited by 732

Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity

Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 683

Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application

Koppaka, V., Thompson, D. C., Chen, Y., Ellermann, M., Nicolaou, K. C., Juvonen, R. O., Petersen, D. R., Deitrich, R. A., Hurley, T. D., & Vasiliou, V. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005538 · Cited by 561

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V., Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 426

High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer

van den Hoogen, C., van der Horst, G., Cheung, H., Buijs, J. T., Down, J. M., Guzmán‐Ramírez, N., Hamdy, F. C., Eaton, C. L., Thalmann, G. N., Cecchini, M. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3806 · Cited by 403

Cuproptosis: mechanisms and links with cancers

Xie, J., Yang, Y., Gao, Y., & He, J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01732-y · Cited by 843

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

Jin, P., Jiang, J., Zhou, L., Huang, Z., Nice, E. C., Huang, C., & Fu, L. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01313-4 · Cited by 299

Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy

Zhou, J., Yu, Q., Song, J., Li, S., Li, X., Kang, B., Chen, H., & Xu, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202213922 · Cited by 242

The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer

Guo, Z., Chen, D., Yao, L., Sun, Y., Li, D., Le, J., Dian, Y., Zeng, F., Chen, X., & Deng, G. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02192-0 · Cited by 221

Disulfiram: a novel repurposed drug for cancer therapy

Chen, L., Li, X., Ren, Y., & Zhang, X. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04216-8 · Cited by 159

The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment

Zhang, H., & Fu, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.008 · Cited by 155

Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens

Lu, Y., Pan, Q., Gao, W., Pu, Y., Luo, K., He, B., & Gu, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121335 · Cited by 149

Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents

Kannappan, V., Ali, M., Small, B., Rajendran, G., Elzhenni, S., Taj, H., Wang, W., & Dou, Q. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.741316 · Cited by 134

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis

Zhang, P., Zhou, C., Ren, X., Jing, Q., Gao, Y., Yang, C., Shen, Y., Zhou, Y., Hu, W., Jin, F., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.103007 · Cited by 126

Protein lipoylation: mitochondria, cuproptosis, and beyond

Lin, C.-H., Chin, Y., Zhou, M., Sobol, R. W., Hung, M., & Tan, M. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.04.002 · Cited by 119

Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative

Pan, M., Zheng, Q., Yu, Y., Ai, H., Xie, Y., Zeng, X., Wang, C., Liu, L., & Zhao, M. (2021) · Nature Communications · doi:10.1038/s41467-020-20359-x · Cited by 108

Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond

Mao, L., Lu, J., Wen, X., Song, Z., Sun, C., Zhao, Y., Huang, F., Chen, S., Jiang, D., Che, W., et al. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00083a · Cited by 104

Cuproptosis: unveiling a new frontier in cancer biology and therapeutics

Feng, Y., Yang, Z., Wang, J., & Hai, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01625-7 · Cited by 91

Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma

Gao, X., Huang, H., Pan, C., Mei, Z., Yin, S., Zhou, L., & Zheng, S. (2022) · Cancers · doi:10.3390/cancers14194715 · Cited by 78

Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway

Huang, X. Y., Hou, Y., Weng, X., Pang, W., Hou, L., Liang, Y., Wang, Y., Du, L., Wu, T., Yao, M., et al. (2021) · Oncogenesis · doi:10.1038/s41389-020-00295-7 · Cited by 71

Cuproptosis in cancer: biological implications and therapeutic opportunities

Li, L., Zhou, H., & Zhang, C. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00608-3 · Cited by 75

Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors

Wang, N., Wang, L., Li, Y., Fu, S.-Y., Xue, X., Jia, L.-N., Yuan, X., Wang, Y., Tang, X., Yang, J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.004 · Cited by 65

Disulfiram: A novel repurposed drug for cancer therapy

Min De, Z. E. N. G., Wu, B., Wei, W., Jiang, Z., Li, P., Quan, Y., & Hu, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002909 · Cited by 66

Disulfiram/Copper induces antitumor activity against gastric cancer via the ROS/MAPK and NPL4 pathways

Liu, Y., Guan, X., Wang, M., Wang, N., Chen, Y., Li, B., Xu, Z., Fu, F., Du, C., & Zheng, Z. (2022) · Bioengineered · doi:10.1080/21655979.2022.2038434 · Cited by 56

Disulfiram as a potent metallo-β-lactamase inhibitor with dual functional mechanisms

Chen, C., Yang, K., Wu, L., Li, J., & Sun, L.-Y. (2020) · Chemical Communications · doi:10.1039/c9cc09074f · Cited by 49

Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis

Nie, D., Chen, C., Li, Y., & Zeng, C. (2022) · Blood Science · doi:10.1097/bs9.0000000000000117 · Cited by 48

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells

Schmidtova, S., Kaľavská, K., Gercakova, K., Čierna, Z., Miklikova, S., Smolková, B., Buociková, V., Miskovska, V., Durinikova, E., Buríková, M., et al. (2019) · Cancers · doi:10.3390/cancers11091224 · Cited by 45

Disulfiram bolsters T‐cell anti‐tumor immunity through direct activation of LCK‐mediated TCR signaling

Wang, Q., Zhu, T., Miao, N., Qu, Y., Wang, Z., Chao, Y., Wang, J., Wu, W., Xu, X., Xu, C., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022110636 · Cited by 45

Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities

Shan, D., Jinling, S., Ren, Y., Zhang, Y., Ba, Y., Luo, P., Cheng, Q., Xu, H., Weng, S., Zuo, A., et al. (2025) · 癌症：英文版 · doi:10.1002/cac2.70005 · Cited by 53

Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway

Majera, D., Skrott, Z., Chroma, K., Merchut-Maya, J. M., Mistrik, M., & Bartek, J. (2020) · Cells · doi:10.3390/cells9020469 · Cited by 43

Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy

Fumoto, S., & Nishida, K. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c20-00008 · Cited by 43

Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy

Lan, Q.-H., Du, C.-C., Yu, R.-J., Zhai, J., Shi, Y., Kou, L., Xiao, J., Lu, C., Zhao, Y., & Yao, Q. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120978 · Cited by 40

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment

Noh, D., Lee, H., Lee, S., Sun, I., & Yoon, H. Y. (2024) · Biomaterials Research · doi:10.34133/bmr.0094 · Cited by 41

Enzalutamide Sensitizes Castration‐Resistant Prostate Cancer to Copper‐Mediated Cell Death

Gao, X., Zhao, H., Liu, J., Wang, M., Dai, Z., Hao, W., Wang, Y., Wang, X., Zhang, M., Liu, P., et al. (2024) · Advanced Science · doi:10.1002/advs.202401396 · Cited by 39

Recent Progress of Copper-Based Nanomaterials in Tumor-Targeted Photothermal Therapy/Photodynamic Therapy

Zhuo, X., Liu, Z., Aishajiang, R., Wang, T., & Yu, D. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092293 · Cited by 38

Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc

Du, C., Guan, X., Liu, Y., Xu, Z., Du, X., Li, B., Wang, M., & Zheng, Z. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-022-04398-3 · Cited by 36

Buffet-style Cu(II) for enhance disulfiram-based cancer therapy

Zhao, L., Wang, X., Lou, H., Jiang, M., Wu, X., Qin, J., Zhang, J., Guan, X., Li, W., Zhang, W., et al. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.06.009 · Cited by 34

Anticancer effects of disulfiram in T-cell malignancies through NPL4-mediated ubiquitin–proteasome pathway

Chen, C., Nie, D., Huang, Y., Yu, X., Chen, Z., Zhong, M., Liu, X., Wang, X., Sui, S., Liu, Z., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ma1121-644r · Cited by 34

Cancer Pro-oxidant Therapy Through Copper Redox Cycling: Repurposing Disulfiram and Tetrathiomolybdate

Rieber, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200628022113 · Cited by 33

USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1

Zhang, Q., Chen, Z., Tang, Q., Wang, Z., Lu, J., You, Y., & Wang, H. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05163-3 · Cited by 32

Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein

Kang, X., Wang, J., Huang, C.-H., Wibowo, F. S., Amin, R., Chen, P., & Li, F. (2022) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2022.102620 · Cited by 32

Apoferritin as a Carrier of Cu(II) Diethyldithiocarbamate and Biomedical Application for Glutathione-Responsive Combination Chemotherapy

Li, X., Du, K., Sun, J., & Feng, F. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b01014 · Cited by 30

Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma

Yoshino, H., Yamada, Y., Enokida, H., Osako, Y., Tsuruda, M., Kuroshima, K., Sakaguchi, T., Sugita, S., Tatarano, S., & Nakagawa, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236119 · Cited by 30

In situ sacrificial growth of metastable copper-enriched nanomedicine for cuproptosis-based synergistic cancer therapy

Zhong, J., Zheng, X., Wen, Y., Wang, S., Zhan, G., & Chen, A. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.145795 · Cited by 28

Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells

Caminear, M. W., Harrington, B. S., Kamdar, R. D., Kruhlak, M. J., & Annunziata, C. M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.762820 · Cited by 28

Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET

Kanellis, D. C., Zisi, A., Skrott, Z., Lemmens, B., Espinoza, J. A., Kosar, M., Björkman, A., Li, X., Arampatzis, S., Bartkova, J., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01167-4 · Cited by 27

Copper homeostasis and cuproptosis represent emerging targets for therapeutic intervention in inflammatory diseases

Yang, W., Xiao, C., Zheng, J., Song, J., & Li, X. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107988 · Cited by 27

Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry

Lu, X., Lin, B., Xu, N., Huang, H., Wang, Y., & Lin, J.-M. (2020) · Talanta · doi:10.1016/j.talanta.2020.120732 · Cited by 23

Nanoscale Metal–Organic Frameworks and Nanoscale Coordination Polymers: From Synthesis to Cancer Therapy and Biomedical Imaging

Cao, X., Feng, N., Huang, Q., & Liu, Y. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01300 · Cited by 23

Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy

Zhou, J., Yu, Q., Song, J., Li, S., Li, X., Kang, B., Chen, H., & Xu, J. (2022) · Angewandte Chemie · doi:10.1002/ange.202213922 · Cited by 23

Disulfiram-loaded nanovesicles hydrogel promotes healing of diabetic wound

Sun, X., Ding, H., Li, X., Wu, Y., & Huang, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05875-4 · Cited by 24

Navigating Transition Metal‐Dependent Cell Death: Mechanisms, Crosstalk, and Future Directions

Song, Q., Yang, Y., & Yang, L. (2025) · Advanced Science · doi:10.1002/advs.202501974 · Cited by 24

Teaching new tricks to old dogs: A review of drug repositioning of disulfiram for cancer nanomedicine

Zhao, P., Tang, X., & Huang, Y. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200127 · Cited by 22

The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics

Zhang, S., Zong, Y., Chen, L., Li, Q., Li, Z., & Meng, R. (2023) · Discover Oncology · doi:10.1007/s12672-023-00729-9 · Cited by 23

Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma

Ni, X., Ye, C., Xi, Y., Zhang, Y., Hou, Y., Zheng, Q., Chen, Z., Wang, L., Weng, X., Yang, C., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176110 · Cited by 23

The Promiscuity of Disulfiram in Medicinal Research

Cvek, B. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00450 · Cited by 21

Drug Repurposing in Oncology: Current Evidence and Future Direction

Zhang, Z., Ji, J., & Liu, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999200820124111 · Cited by 20

Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets

Nasrollahzadeh, A., Momeny, M., Fasehee, H., Yaghmaie, M., Bashash, D., Hassani, S., Mousavi, S. A., & Ghaffari, S. H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119087 · Cited by 20

A phenotypic screening platform utilising human spermatozoa identifies compounds with contraceptive activity

Gruber, F. S., Johnston, Z. C., Barratt, C. L. R., & Andrews, P. D. (2020) · eLife · doi:10.7554/elife.51739 · Cited by 20

NIR-activatable proenzyme DSF/CuS@M for synergistic in situ chemotherapy/CDT/PTT/cuproptosis-based antitumor therapy

Xu, L., Chen, Q., Qian, Y., Wang, J., Wang, C., Fan, R., Shen, J., & Shen, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161733 · Cited by 22

Addressing misconceptions in dithiocarbamate chemistry

Pugh, D., & Hogarth, G. (2025) · Dalton Transactions · doi:10.1039/d5dt01085c · Cited by 19

Dextran-engineered Cu-MOF nanozyme with multi-enzyme mimetic cascade for cuproptosis-enhanced synergistic therapy in triple-negative breast cancer

Wang, Y.-E., Yang, H. S., Zhao, S., Tian, L., Wu, W., Chen, Y., Wu, X., Zhang, T., Linghu, K., Liu, S., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146920 · Cited by 19

The interaction of disulfiram and H2S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth

Read, E., Milford, J., Zhu, J., Wu, L., Bilodeau, M., & Yang, G. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115642 · Cited by 18

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characterization in ovarian cancer

Zhang, J., Lu, M., Xu, H., Ren, F., & Zhu, L. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02756-y · Cited by 17

Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model

Serra, R., Zhao, T., Huq, S., Gorelick, N. L., Casaos, J., Cecia, A. F., Mangraviti, A., Eberhart, C. G., Bai, R.-Y., Olivi, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251957 · Cited by 16

Recent advances in copper homeostasis-involved tumor theranostics

Ren, X., Luo, X., Wang, F., Wan, L., Wang, X., Xiong, J., Ye, M., Rui, S., Liu, Z., Wang, S., et al. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100948 · Cited by 16

A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment

Chromá, K., Škrott, Z., Gurský, J., Bačovský, J., Moudrý, P., Buchtová, T., Mistrík, M., & Bártek, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04651-w · Cited by 17

Targeting metalloptosis in tumor therapy: from molecular mechanisms to application of metal nanoparticles

Wang, J., Tian, Q., Liu, Y., Cai, C., Fu, S., Li, J., Guan, Y., Liao, X., Su, D., Sun, T., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02414-7 · Cited by 18

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

Meraz-Torres, F., Niessner, H., Plöger, S., Riel, S., Schörg, B. F., Casadei, N., Kneilling, M., Schaller, M., Flatz, L., Maček, B., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02941-5 · Cited by 15

Cuproptosis in cancer therapy: mechanisms, therapeutic application and future prospects

Hu, J., Zhu, J., Chen, T., Zhao, Y., Xu, Q., & Wang, Y. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01877j · Cited by 17

ALDH1A1 Gene Expression and Cellular Copper Levels between Low and Highly Metastatic Osteosarcoma Provide a Case for Novel Repurposing with Disulfiram and Copper

Mandell, J. B., Douglas, N., Ukani, V., Beumer, J. H., Guo, J., Payne, J., Newman, R., Mancinelli, L., Intini, G., Anderson, C. J., et al. (2022) · Sarcoma · doi:10.1155/2022/7157507 · Cited by 15

Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells

Majera, D., & Mistrík, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249431 · Cited by 13

Isothiocyanates (ITCs) 1-(Isothiocyanatomethyl)-4-phenylbenzene and 1-Isothiocyanato-3,5-bis(trifluoromethyl)benzene—Aldehyde Dehydrogenase (ALDH) Inhibitors, Decreases Cisplatin Tolerance and Migratory Ability of NSCLC

Kryczka, J., Kryczka, J. M., Janczewski, Ł., Gajda, A., Fraczyk, A., Boncela, J., Kolesińska, B., & Brzeziańska‐Lasota, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158644 · Cited by 12

Polydopamine-Modified Copper Coordination Mesoporous Silica Nanoparticles Loaded with Disulfiram for Synergistic Chemo-Photothermal Therapy

Ling, J., Cai, Y., Feng, H., Liu, Z., & Ouyang, X. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040512 · Cited by 12

A Ferritin–Albumin–Cu Nanoparticle that Efficaciously Delivers Copper(II) Ions to a Tumor and Improves the Therapeutic Efficacy of Disulfiram

Xu, N., Yang, Y., Chen, L., & Lin, J. (2020) · ACS Omega · doi:10.1021/acsomega.0c00293 · Cited by 12

Cannabidiol‐induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET

Buchtova, T., Skrott, Z., Chroma, K., Rehulka, J., Dzubak, P., Hajduch, M., Lukac, D., Arampatzis, S., Bartek, J., & Mistrik, M. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13114 · Cited by 11

Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death

Xi, J., Lei, S.-Y., Chen, J., Liu, J., Shan, C., Sun, X., Zheng, Q., & Shi, X. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02558-x · Cited by 12

A nanosystem of copper(II)-disulfiram for cancer treatment with high efficacy and few side effects

Zhao, L., Wang, X., Jiang, M., Wu, X., Zhang, M., Guan, X., Ma, J., & Zhang, W. (2021) · Frontiers of Materials Science · doi:10.1007/s11706-021-0576-2 · Cited by 11

Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part I

Chang, M. R., Rusanov, D. A., Arakelyan, J., Alshehri, M. M., Asaturova, A. V., Kireeva, G. S., Babak, M. V., & Ang, W. H. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214923 · Cited by 11

Disulfiram and metformin combination anticancer effect reversible partly by antioxidant nitroglycerin and completely by NF-κB activator mebendazole in hamster fibrosarcoma

Popović, K. J., Popović, D. J., Miljković, D., Popović, J. K., Lalošević, D., Poša, M., & Čapo, I. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112168 · Cited by 10

Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells

Löffelmann, M., Škrott, Z., Majera, D., Štarha, P., Kryštof, V., & Mistrík, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115790 · Cited by 8

Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPGPreprint

Carvalho, D. M., Temelso, S., Mackay, A. G., Pemberton, H. N., Rogers, R. F., Kessler, K., Izquierdo, E., Bjerke, L. M., Salom, J. F., Clarke, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.29.424674 · Cited by 10

Nuclear bodies protect phase separated proteins from degradation in stressed proteomePreprint

Jung, K. H., Sun, J., Hsiung, C., Lian, X. L., Liu, Y., & Zhang, X. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.19.537522 · Cited by 8

The Emerging Roles of Aldehyde Dehydrogenase in Acute Myeloid Leukemia and Its Therapeutic Potential

Ayatollahi, H., Rahmati, A., Goudarzi, S., Sheikhi, M., Siyadat, P., & Ferns, G. A. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220610154043 · Cited by 7

Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)

Ai, L., Yi, N., Qiu, C., Huang, W., Zhang, K., Hou, Q., Jia, L., Li, H., & Liu, L. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5634 · Cited by 9

The ALDH2/PolG2 axis enhances mitochondrial biogenesis via transcriptional regulation of Nrf2 and promotes chemotherapy resistance in acute myeloid leukaemia

Hu, X., Hu, T., Cao, S., Jiang, L., Zhou, Y., Fang, Q., & Wang, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07927-z · Cited by 6

Possible Therapeutic Potential of Disulfiram for Multiple Myeloma

Drozdková, D. W., & Trtková, K. S. (2021) · Current Oncology · doi:10.3390/curroncol28030193 · Cited by 6

The role of copper homeostasis and cuproptosis in cerebrovascular diseases:A novel therapeutic target

Fang, X., Wang, X., Hao, M., Zhong, G., Gao, M., Pan, Y., Pan, Y., Yang, H., Yin, X., Shen, J., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177649 · Cited by 5

Self-supplying Cu 2+ and H 2 O 2 synergistically enhancing disulfiram-mediated melanoma chemotherapy

Gao, Y., Cai, X., Zou, W., Tang, X., Jiang, L., Hao, J., Zheng, Y., Ye, X., Ying, T., & Li, A. (2024) · RSC Advances · doi:10.1039/d4ra01075b · Cited by 5

Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway

Meng, Y. G., Wu, Q., Zhang, M., Lai, M., Chen, W., Yang, J., Li, J., & Cao, J. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200405 · Cited by 5

Nuclear bodies protect phase separated proteins from degradation in stressed proteomePreprint

Jung, K. H., Sun, J., Hsiung, C., Lian, X. L., Liu, Y., & Zhang, X. (2023) · doi:10.7554/elife.88237.1 · Cited by 5

Programmable “triple attack” cancer therapy through in situ activation of disulfiram toxification combined with phototherapeutics

He, Q., Jia, B.-X., Luo, Z.-R., Wang, Y.-K., Zhang, B., Liao, T., Guang, X.-Y., Feng, Y.-F., Zhang, Z., & Zhou, B. (2024) · Chemical Science · doi:10.1039/d3sc05300h · Cited by 4

DNA polymerase α/primase extraction from chromatin by VCP/p97 restricts ATR activation during unperturbed DNA replication

Rodríguez‐Acebes, S., Martín-Rufo, R., Gómez-Moya, A., Churcher, S. B., Fernández-Llorente, A., de la Vega-Barranco, G., Perona, A., Oroz, P., Martín‐Doncel, E., Toledo, L. I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60077-w · Cited by 5

Polatuzumab vedotin and CD79B : A study of efficacy in R‐CHOP‐resistant diffuse large B‐cell lymphoma

Munz, N., Arribas, A. J., Pittau, R. B., Simonetta, F., Stüssi, G., & Bertoni, F. (2025) · British Journal of Haematology · doi:10.1111/bjh.70185 · Cited by 4

Repurposing Disulfiram as a Chemo-Therapeutic Sensitizer: Molecular Targets and Mechanisms

Sun, F., Wang, H., Nie, J. J., & Hong, B. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666220415102553 · Cited by 4

Disulfiram enhances chemotherapeutic effects of doxorubicin liposomes against human hepatocellular carcinoma via activating ROS-induced cell stress response pathways

Lin, H., Sun, F., Li, T., Zhang, Y., Guo, X., Li, M., Liang, M., Zhou, X., & Fang, Z. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-022-04481-9 · Cited by 4

Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer

Du, R., Sun, F., Li, K., Qi, J., Zhong, W., Wang, W., Sun, Q., Deng, Q., Wang, H., Nie, J. J., et al. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230516161200 · Cited by 4

NPLOC4 is a potential target and a poor prognostic signature in lung squamous cell carcinoma

Wang, N., Zhu, D., Liu, Y., Wu, J., Wang, M., Jin, S., Fu, F., Li, B., Ji, H., Du, C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47782-6 · Cited by 5

Disulfiram activates autophagy via proteasome inhibition and c-Fos/beclin-1 upregulation, synergizing with chloroquine

Wang, K., Wang, Z., Peng, W., Li, G., Xiao, H., Zhong, Z., He, Y., Yu, Y., Song, Y., Xiang, L., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02899-7 · Cited by 4

Ambivalent Copper: Mechanistically Distinct Immune Effects Driving Innovation in Cancer Nanomedicine

Heroux, D., Sun, X., Nosrati, Z., & Bally, M. B. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010075 · Cited by 4

Copper homeostasis and cuproptosis in cancer: mitochondrial metabolic dependency and nanomedicine-based therapeutic strategies

Han, X., Peng, Z., Cao, K., & Liang, G. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02352-9 · Cited by 3

Preparation of disulfiram-Cu2+-polylactide nanofibrous membranes via electrostatic spinning and evaluation of their in vitro anticancer effects

Liu, L., Liu, Z., Tian, L., Huang, Z., Zhang, W., & Li, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137469 · Cited by 2

Drug Repurposing for Targeting Cancer Stem-like Cells in Glioblastoma

Sousa‐Coelho, A. L. D., Solaković, B., Bento, A. D., & Fernandes, M. T. (2025) · Cancers · doi:10.3390/cancers17182999 · Cited by 2

Quantitative proteomics analysis reveals novel insights into mechanisms of action of disulfiram (DSF)

Zheng, P., Liu, C., Wu, Y., Xu, R., Chen, Y., Hu, F., Chen, Z., & Zhang, T. (2021) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.202100031 · Cited by 2

Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions

Sertedaki, E., & Kotsinas, A. (2020) · Cells · doi:10.3390/cells9051210 · Cited by 2

Disulfiram';s Anticancer Activity: Evidence and Mechanisms

Jiao, Y., Hannafon, B. N., & Ding, W. (2016) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666160504095040 · Cited by 112

Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation

Guo, F., Yang, Z., Kulbe, H., Albers, A. E., Sehouli, J., & Kaufmann, A. M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109371 · Cited by 78

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807

Repositioning an Old Anti-Alcoholism Drug: Disulfiram as a Selective, Effective and Economical Anticancer Agent

Soave, C. L., & Viola-Rhenals, M. (2016) · Journal of Developing Drugs · doi:10.4172/2329-6631.1000e147 · Cited by 4

Disulfiram (Antabuse) acts as a potent chemo-radio sensitizer and abolishes stem cells in HNSCC cell lines in vitro

Yao, W. (2020) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-27357